NDC 0078-1091

SCEMBLIX

Asciminib

SCEMBLIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Asciminib Hydrochloride.

• Product ID: 0078-1091_603416c5-f2d1-4d03-a437-71be34553988
• NDC: 0078-1091
• Product Type: Human Prescription Drug
• Proprietary Name: SCEMBLIX
• Generic Name: Asciminib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-10-29
• Marketing Category: NDA /
• Application Number: NDA215358
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: ASCIMINIB HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-1091-20

60 TABLET, FILM COATED in 1 BOTTLE (0078-1091-20)

• Marketing Start Date: 2021-10-29
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SCEMBLIX" or generic name "Asciminib"

NDC	Brand Name	Generic Name
0078-1091	SCEMBLIX	asciminib
0078-1098	SCEMBLIX	asciminib